- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Stereotaxis Inc (STXS)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: STXS (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $4.25
1 Year Target Price $4.25
| 2 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -44.26% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 221.18M USD | Price to earnings Ratio - | 1Y Target Price 4.25 |
Price to earnings Ratio - | 1Y Target Price 4.25 | ||
Volume (30-day avg) 4 | Beta 1.47 | 52 Weeks Range 1.54 - 3.59 | Updated Date 12/15/2025 |
52 Weeks Range 1.54 - 3.59 | Updated Date 12/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -78.56% | Operating Margin (TTM) -69.75% |
Management Effectiveness
Return on Assets (TTM) -26.42% | Return on Equity (TTM) -170.24% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 221524688 | Price to Sales(TTM) 7.35 |
Enterprise Value 221524688 | Price to Sales(TTM) 7.35 | ||
Enterprise Value to Revenue 7.37 | Enterprise Value to EBITDA -10.06 | Shares Outstanding 93324763 | Shares Floating 66055267 |
Shares Outstanding 93324763 | Shares Floating 66055267 | ||
Percent Insiders 29.27 | Percent Institutions 46.53 |
About Stereotaxis Inc
Exchange NYSE MKT | Headquaters Saint Louis, MO, United States | ||
IPO Launch date 2004-08-12 | CEO & Chairman Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 139 | Website https://www.stereotaxis.com |
Full time employees 139 | Website https://www.stereotaxis.com | ||
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

